DrugPatentWatch Database Preview
Details for Patent: 10,045,959
Which drugs does patent 10,045,959 protect, and when does it expire?
Patent 10,045,959 protects RAVICTI and is included in one NDA.
This patent has thirty-two patent family members in twenty-three countries.
Summary for Patent: 10,045,959
| Title: | Methods of therapeutic monitoring of nitrogen scavenging drugs |
| Abstract: | The present disclosure provides methods for evaluating daily ammonia exposure based on a single fasting ammonia blood level measurement, as well as methods that utilize this technique to adjust the dosage of a nitrogen scavenging drug, determine whether to administer a nitrogen scavenging drug, and treat nitrogen retention disorders. |
| Inventor(s): | Scharschmidt; Bruce (San Francisco, CA), Mokhtarani; Masoud (Walnut Creek, CA) |
| Assignee: | Horizon Therapeutics, LLC (Lake Forest, IL) |
| Application Number: | 15/944,416 |
|
Patent Claim Types: see list of patent claims | Use; |
Drugs Protected by US Patent 10,045,959
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Horizon Therap | RAVICTI | glycerol phenylbutyrate | LIQUID;ORAL | 203284-001 | Feb 1, 2013 | RX | Yes | Yes | Start Trial | Start Trial | TREATMENT OF A UREA CYCLE DISORDER | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 10,045,959
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Australia | 2012316750 | Start Trial | |||
| Australia | 2017251691 | Start Trial | |||
| Brazil | 112014007357 | Start Trial | |||
| Canada | 2850391 | Start Trial | |||
| Chile | 2014000783 | Start Trial | |||
| China | 104039358 | Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
